Teva Pharmaceutical Industries Net Profit Margin 2010-2025 | TEVA

Teva Pharmaceutical Industries net profit margin for the quarter ending March 31, 2025 was -7.74%.

  • Teva Pharmaceutical Industries average net profit margin for 2024 was -5.35%, a 53.44% increase from 2023.
  • Teva Pharmaceutical Industries average net profit margin for 2023 was -11.49%, a 28.81% decline from 2022.
  • Teva Pharmaceutical Industries average net profit margin for 2022 was -8.92%, a 13.65% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.

Teva Pharmaceutical Industries Net Profit Margin 2010-2025 | TEVA

  • Teva Pharmaceutical Industries average net profit margin for 2024 was -5.35%, a 53.44% increase from 2023.
  • Teva Pharmaceutical Industries average net profit margin for 2023 was -11.49%, a 28.81% decline from 2022.
  • Teva Pharmaceutical Industries average net profit margin for 2022 was -8.92%, a 13.65% increase from 2021.

Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M